Top Markets
Coin of the day
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Classificação em ações #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Preço da ação
$3.78
Última sincronização: 2026-08-21
Valor de mercado
$71.20M
Variação (1 dia)
2.24%
Variação (1 ano)
-43.37%
País
FR
Negociar MaaT Pharma S.A. (MAAT)

Categoria

Histórico de preços das ações de MaaT Pharma S.A. (MAAT)
Preço de fecho mais alto: $3.53 em 2026-08-01

Preço de fecho mais baixo: $15.22 em 2021-11-01
Histórico de preços das ações da MaaT Pharma S.A. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 10.63%
2025 -39.72%
2024 11.45%
2023 -18.97%
2022 -38.00%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH